References
- Kristensen L. E., Christensen R., Bliddal H., Geborek P., Danneskiold‐Samsoe B., Saxne T. The number needed to treat for adalimumab, etanercept, and infliximab based on ACR50 response in three randomized controlled trials on established rheumatoid arthritis: a systematic literature review. Scand J Rheumatol 2007; 36: 411–17
- Ravindran V., Scott D. L., Choy E. H. A systematic review and meta‐analysis of efficacy and toxicity of disease modifying anti‐rheumatic drugs and biologic agents for psoriatic arthritis. Ann Rheum Dis 2007, DOI: 10.1136/ard.2007.072652
- Antoni C., Krueger G. G., de Vlam K., Birbara C., Beutler A., Guzzo C., et al. Infliximab improves signs and symptoms of psoriatic arthritis: results of the IMPACT 2 trial. Ann Rheum Dis 2005; 64: 1150–7
- Antoni C. E., Kavanaugh A., Kirkham B., Tutuncu Z., Burmester G. R., Schneider U., et al. Sustained benefits of infliximab therapy for dermatologic and articular manifestations of psoriatic arthritis: results from the Infliximab Multinational Psoriatic Arthritis Controlled Trial (IMPACT). Arthritis Rheum 2005; 52: 1227–36
- Genovese M. C., Mease P. J., Thomson G. T., Kivitz A. J., Perdok R. J., Weinberg M. A., et al. Safety and efficacy of adalimumab in treatment of patients with psoriatic arthritis who had failed disease modifying antirheumatic drug therapy. J Rheumatol 2007; 34: 1040–50
- Mease P. J., Gladman D. D., Ritchlin C. T., Ruderman E. M., Steinfeld S. D., Choy E. H., et al. Adalimumab for the treatment of patients with moderately to severely active psoriatic arthritis: results of a double‐blind, randomized, placebo‐controlled trial. Arthritis Rheum 2005; 52: 3279–89
- Mease P. J., Goffe B. S., Metz J., VanderStoep A., Finck B., Burge D. J. Etanercept in the treatment of psoriatic arthritis and psoriasis: a randomised trial. Lancet 2000; 356: 385–90
- Mease P. J., Kivitz A. J., Burch F. X., Siegel E. L., Cohen S. B., Ory P., et al. Etanercept treatment of psoriatic arthritis: safety, efficacy, and effect on disease progression. Arthritis Rheum 2004; 50: 2264–72